OUP user menu

Nutraceuticals and their preventive or potential therapeutic value in Parkinson's disease

Jianfei Chao , Yen Leung , Mingfu Wang , Raymond Chuen-Chung Chang
DOI: http://dx.doi.org/10.1111/j.1753-4887.2012.00484.x 373-386 First published online: 1 July 2012

Abstract

Parkinson's disease (PD) is the second most common aging-related disorder in the world, after Alzheimer's disease. It is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and other parts of the brain, leading to motor impairment, cognitive impairment, and dementia. Current treatment methods, such as L-dopa therapy, are focused only on relieving symptoms and delaying progression of the disease. To date, there is no known cure for PD, making prevention of PD as important as ever. More than a decade of research has revealed a number of major risk factors, including oxidative stress and mitochondrial dysfunction. Moreover, numerous nutraceuticals have been found to target and attenuate these risk factors, thereby preventing or delaying the progression of PD. These nutraceuticals include vitamins C, D, E, coenzyme Q10, creatine, unsaturated fatty acids, sulfur-containing compounds, polyphenols, stilbenes, and phytoestrogens. This review examines the role of nutraceuticals in the prevention or delay of PD as well as the mechanisms of action of nutraceuticals and their potential applications as therapeutic agents, either alone or in combination with current treatment methods.

  • dietary supplement
  • neuroprotection
  • nutraceuticals
  • Parkinson's disease
View Full Text

Log in through your institution